Θεοδώρα Παππά

Dana-Farber Cancer Institute — United States

Medicine · Health Sciences

23h-index2.1kcitations144works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(71), Thyroid Disorders and Treatments(16), BRCA gene mutations in cancer(15), Hormonal Regulation and Hypertension(15), Pituitary Gland Disorders and Treatments(14)

Publications143 total

A context-augmented large language model for accurate precision oncology medicine recommendations
Cancer Cell·2026Open Access
Conserved Neuronal-like and Secretory Programs Define the Spatial Architecture of Gastroenteropancreatic Neuroendocrine Tumors
2025Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
Supplementary Table S3 from Additional Oncogenic Alterations in <i>RAS</i>-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2025Open Access
MON-380 Development of a Prognostic Cell Cycle Progression Score in Preoperative Thyroid Tumor Samples to Predict Prognosis
Journal of the Endocrine Society·2025Open Access
Can Molecular Profiling Predict Invasion in <i>RAS</i> -Mutant Thyroid Tumors?
Clinical Thyroidology·2025
How to Manage and Screen for Thyroid Nodules and Cancer in PTEN Hamartoma Tumor Syndrome: Recommendations from the International PHTS Consensus Guidelines Working Group
Clinical Thyroidology·2025
Dual immune checkpoint inhibition in advanced incurable radioidine-refractory differentiated thyroid carcinoma (RAIR DTC), anaplastic (ATC), and medullary thyroid carcinoma (MTC): Long-term survival results from phase II clinical trial.
Journal of Clinical Oncology·2025
Implementing a context-augmented large language model to guide precision cancer medicine
2025· 1 citedOpen Access
Medullary thyroid carcinoma
Elsevier eBooks·2025
Abstract B024: Personalized tumor-informed circulating tumor (ct) DNA for advanced thyroid carcinoma
Clinical Cancer Research·2024· 1 cited
Personalized, disease-stage specific, rapid identification of immunosuppression in sepsis
Frontiers in Immunology·2024· 2 citedOpen Access
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma
JAMA Oncology·2024· 25 citedOpen Access
MON-785 Immunogenomic Analysis Of Advanced Thyroid Cancer Reveals A Distinct Immune Devoid Profile In RAS Mutant Tumors
Journal of the Endocrine Society·2024Open Access
6398 Activating Mutations in a Primate-Specific Enhancer of MIR7-2/MIR1179 Are a Common Cause of Resistance to Thyrotropin
Journal of the Endocrine Society·2024Open Access
Supplementary Table S1 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Data from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S3 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
Supplementary Table S2 from Additional Oncogenic Alterations in RAS-Driven Differentiated Thyroid Cancers Associate with Worse Clinicopathologic Outcomes
2024Open Access
page 1 of 8Next →

Frequent Co-authors

George Piaditis(15), Labrini Papanastasiou(11), Maria Alevizaki(10), Samuel Refetoff(10), Αthina Markou(9), Gregory Kaltsas(9), Erik K. Alexander(8), Sara Ahmadi(7), Ellen Marqusee(7), Iñigo Landa(7), Vaios Tsiavos(5), Ioannis I. Androulakis(5), Athanasios Bikas(5), George P. Chrousos(4), Stelios Fountoulakis(4), Justine A. Barletta(4), Roy E. Weiss(4), Alexandra M. Dumitrescu(4), Christianna Samara(4), Georgios Papadakis(4)